UTMD
Utah Medical Products, Inc.
UTMD's fundamentals are mixed, but it looks expensive: trading at 22x earnings, above its usual 20x. Its downside scenario is about three times its upside.
UTMD Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Healthy | |
| Strong |
UTMD's profitability, cash flow and balance sheet are currently healthy, but its revenue is under pressure.
UTMD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $50.18 | -32% |
| Fair | 20x | $66.55 | -9.6% |
| Current | 22x | $73.63 | — |
| Expensive | 26x | $84.11 | +14% |
Historical ranges are pointers, not guarantees.
UTMD's PE is in its expensive range at 22x.
UTMD Forward outlook
There aren't enough analyst estimates for UTMD to show an outlook.
UTMD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.28 | -12% |
| Q1 2026 | $3.38 | -11% |
| Q4 2025 | $3.48 | -12% |
| Q3 2025 | $3.54 | -17% |
| Q2 2025 | $3.74 | -14% |
| Q1 2025 | $3.78 | -16% |
| Q4 2024 | $3.95 | -14% |
| Q3 2024 | $4.27 | -8% |
UTMD's earnings per share have fallen from their peak: $3.28 over the past year, against $4.74 in mid-2023.
UTMD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $8.5M | -14% |
| Q1 2026 | $8.7M | -10% |
| Q4 2025 | $9M | -1.2% |
| Q3 2025 | $9.8M | -1.9% |
| Q2 2025 | $10M | -4.3% |
| Q1 2025 | $9.7M | -14% |
| Q4 2024 | $9.2M | -26% |
| Q3 2024 | $10M | -20% |
UTMD's revenue has slid since its 2022 peak: $9M last quarter, down 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 31% | -1.1 points |
| Q1 2026 | 29% | -3.1 points |
| Q4 2025 | 27% | -5 points |
| Q3 2025 | 27% | -6.8 points |
| Q2 2025 | 32% | -1 points |
| Q1 2025 | 32% | -1.8 points |
| Q4 2024 | 32% | 0 points |
| Q3 2024 | 33% | +1.7 points |
UTMD's operating margin was 31% last quarter, down 1.1 points from the same quarter a year ago.
UTMD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $1.2M | -56% |
| Q1 2026 | $3M | -30% |
| Q4 2025 | $3.4M | +15% |
| Q3 2025 | $3.9M | +2.2% |
| Q2 2025 | $2.8M | +6.4% |
| Q1 2025 | $4.3M | -19% |
| Q4 2024 | $2.9M | -44% |
| Q3 2024 | $3.8M | -24% |
UTMD's free cash flow has been positive every quarter for seven years: $11M over the past year, down 17% from the year before.
UTMD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -1K shares |
| 1 year | -1.9% | -62K shares |
| 3 years | -13% | -455K shares |
| 5 years | -13% | -471K shares |
| Available history | -15% | -553K shares |
UTMD has 3M diluted shares, down 1.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $78,000 |
| Q1 2026 | $128,000 |
| Q4 2025 | $994,000 |
| Q3 2025 | $653,000 |
| Q2 2025 | $3.5M |
| Q1 2025 | $3.2M |
| Q4 2024 | $6.7M |
| Q3 2024 | $3.9M |
UTMD spent $2M buying back its own shares over the past year, down 89% from the year before.
UTMD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -6.9x | Net Cash |
| Q1 2026 | -6.4x | Net Cash |
| Q4 2025 | -6.0x | Net Cash |
| Q3 2025 | -5.7x | Net Cash |
| Q2 2025 | -5.3x | Net Cash |
| Q1 2025 | -5.3x | Net Cash |
| Q4 2024 | -5.1x | Net Cash |
| Q3 2024 | -5.0x | Net Cash |
UTMD has more cash than debt.
UTMD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.3 | Neutral |
| Stochastic | 45.8 | Neutral |
UTMD's weekly RSI is 56 (neutral) and its Stochastic is 46 (neutral).
UTMD PE vs Healthcare Sector
| Metric | UTMD | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 26x | 13% below |
| PE % | 68 | 29 | 39 pts above |
UTMD is trading at 22x earnings, a 13% discount to the Healthcare sector's median of 26x.
UTMD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $73.2 | 0.6% above |
| 20 week MA | $71.7 | 2.6% above |
| 50 week MA | $66.9 | 10% above |
| 100 week MA | $62.5 | 18% above |
| 200 week MA | $71.0 | 3.7% above |
UTMD has climbed back above all five of its weekly moving averages, and it's now 3.7% above its 200-week average.
UTMD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $108.4 | $85.5 | -21% |
| 2021 | $85.5 | $97.9 | +15% |
| 2022 | $97.9 | $93.6 | -4.4% |
| 2023 | $93.6 | $84.2 | -10% |
| 2024 | $84.2 | $61.9 | -27% |
| 2025 | $61.9 | $56.8 | -8.3% |
| 2026 YTD | $56.8 | $73.6 | +30% |
UTMD has finished four years in a row lower, and it's up 30% so far in 2026.